Trial intelligence / Profile preview

CBD-bFGF and Collagen/BMMNCs for Endometrial Regeneration

NCT04233892Phase 2Unknown

Start
Apr 2020
Primary completion
Dec 2022
Modality
Implantable Devices, Implantable Hydrogels, Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 2 trial of cannabidiol + basic fibroblast growth factor, collagen + bone marrow mononuclear cells in infertility, endometrial fibrosis. Status: unknown.

02

Drugs

cannabidiol + basic fibroblast growth factorcollagen + bone marrow mononuclear cells
03

Conditions

infertilityendometrial fibrosis

Beyond the preview

Go deeper on NCT04233892.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04233892.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call